Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?

Cetinkalp, Sevki; Simsir, Ilgin Yildirim; Sahin, Fahri; Saydam, Guray; Ural, Ali Ugur; Yilmaz, Candeger.

Cetinkalp S; Ege University Medical Faculty, Department of Endocrinology and Metabolism, Izmir, Turkey.
Simsir IY; Ege University Medical Faculty, Department of Endocrinology and Metabolism, Izmir, Turkey.
Sahin F; Ege University Medical Faculty, Department of Hematology, Izmir, Turkey.
Saydam G; Ege University Medical Faculty, Department of Hematology, Izmir, Turkey.
Ural AU; Gulhane Military Medical Academy, Department of Hematology, Ankara, Turkey.
Yilmaz C; Ege University Medical Faculty, Department of Endocrinology and Metabolism, Izmir, Turkey.

Saudi Pharm J ; 23(1): 14-21, 2015 Jan.

Article en En | MEDLINE | ID: mdl-25685038